246 related articles for article (PubMed ID: 32379293)
1. Considerations in Human Papillomavirus-Associated Oropharyngeal Cancer Screening: A Review.
Day AT; Fakhry C; Tiro JA; Dahlstrom KR; Sturgis EM
JAMA Otolaryngol Head Neck Surg; 2020 Jul; 146(7):656-664. PubMed ID: 32379293
[TBL] [Abstract][Full Text] [Related]
2. Is 2045 the best we can do? Mitigating the HPV-related oropharyngeal cancer epidemic.
Schuman A; Anderson KS; Day AT; Ferrell J; Sturgis EM; Dahlstrom KR
Expert Rev Anticancer Ther; 2022 Jul; 22(7):751-761. PubMed ID: 35679626
[TBL] [Abstract][Full Text] [Related]
3. Projected Association of Human Papillomavirus Vaccination With Oropharynx Cancer Incidence in the US, 2020-2045.
Zhang Y; Fakhry C; D'Souza G
JAMA Oncol; 2021 Oct; 7(10):e212907. PubMed ID: 34473210
[TBL] [Abstract][Full Text] [Related]
4. Could the human papillomavirus vaccination be cost-effective in males for the prevention of oropharyngeal cancer?
Isaranuwatchai W; Graham DM; Siu LL; Hoch JS
Expert Rev Pharmacoecon Outcomes Res; 2014 Dec; 14(6):763-5. PubMed ID: 25095728
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus in cervical cancer and oropharyngeal cancer: One cause, two diseases.
Berman TA; Schiller JT
Cancer; 2017 Jun; 123(12):2219-2229. PubMed ID: 28346680
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Implication of Persistent Human Papillomavirus Type 16 DNA Detection in Oral Rinses for Human Papillomavirus-Related Oropharyngeal Carcinoma.
Rettig EM; Wentz A; Posner MR; Gross ND; Haddad RI; Gillison ML; Fakhry C; Quon H; Sikora AG; Stott WJ; Lorch JH; Gourin CG; Guo Y; Xiao W; Miles BA; Richmon JD; Andersen PE; Misiukiewicz KJ; Chung CH; Gerber JE; Rajan SD; D'Souza G
JAMA Oncol; 2015 Oct; 1(7):907-15. PubMed ID: 26226294
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic accuracy of serum antibodies to human papillomavirus type 16 early antigens in the detection of human papillomavirus-related oropharyngeal cancer.
Dahlstrom KR; Anderson KS; Field MS; Chowell D; Ning J; Li N; Wei Q; Li G; Sturgis EM
Cancer; 2017 Dec; 123(24):4886-4894. PubMed ID: 28898394
[TBL] [Abstract][Full Text] [Related]
8. A cost-effectiveness analysis of human papillomavirus vaccination of boys for the prevention of oropharyngeal cancer.
Graham DM; Isaranuwatchai W; Habbous S; de Oliveira C; Liu G; Siu LL; Hoch JS
Cancer; 2015 Jun; 121(11):1785-92. PubMed ID: 25867018
[TBL] [Abstract][Full Text] [Related]
9. Surveillance of human papillomavirus through salivary diagnostics - A roadmap to early detection of oropharyngeal cancer in men.
Wijesekera A; Weeramange CE; Vasani S; Kenny L; Knowland E; Seneviratne J; Punyadeera C
Tumour Virus Res; 2024 Jun; 17():200278. PubMed ID: 38442788
[TBL] [Abstract][Full Text] [Related]
10. HPV-related oropharyngeal cancer: a review on burden of the disease and opportunities for prevention and early detection.
Timbang MR; Sim MW; Bewley AF; Farwell DG; Mantravadi A; Moore MG
Hum Vaccin Immunother; 2019; 15(7-8):1920-1928. PubMed ID: 31050595
[TBL] [Abstract][Full Text] [Related]
11. Societal cost of oropharyngeal cancer by human papillomavirus status, cancer stage, and subsite.
Silfverschiöld M; Sjövall J; Wennerberg J; Östensson E; Greiff L
PLoS One; 2019; 14(7):e0220534. PubMed ID: 31356646
[TBL] [Abstract][Full Text] [Related]
12. The potential impact of prophylactic human papillomavirus vaccination on oropharyngeal cancer.
Guo T; Eisele DW; Fakhry C
Cancer; 2016 Aug; 122(15):2313-23. PubMed ID: 27152637
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus-related oropharyngeal cancer in the HIV-infected population.
Wang CC; Palefsky JM
Oral Dis; 2016 Apr; 22 Suppl 1():98-106. PubMed ID: 27109278
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of HPV vaccination in the context of high cervical cancer incidence and low screening coverage.
Võrno T; Lutsar K; Uusküla A; Padrik L; Raud T; Reile R; Nahkur O; Kiivet RA
Vaccine; 2017 Nov; 35(46):6329-6335. PubMed ID: 28899625
[TBL] [Abstract][Full Text] [Related]
15. The prevalence of human papillomavirus in oropharyngeal cancer is increasing regardless of sex or race, and the influence of sex and race on survival is modified by human papillomavirus tumor status.
Faraji F; Rettig EM; Tsai HL; El Asmar M; Fung N; Eisele DW; Fakhry C
Cancer; 2019 Mar; 125(5):761-769. PubMed ID: 30521092
[TBL] [Abstract][Full Text] [Related]
16. Correlates of human papillomavirus vaccination intent for oropharyngeal cancer prevention among gay and bisexual men living in the United States.
Stull C; Bennis SL; Rosser BRS; Wilkerson JM; Zoschke IN; Jiang Z; Nyitray AG; Khariwala SS; Ross MW
J Am Dent Assoc; 2024 Jan; 155(1):26-38.e1. PubMed ID: 37988048
[TBL] [Abstract][Full Text] [Related]
17. A Multi-state Evaluation of Oral Health Students' Knowledge of Human Papillomavirus-Related Oropharyngeal Cancer and HPV Vaccination.
Rutkoski H; Tay DL; Dixon BL; Pinzon LM; Mooney R; Winkler JR; Kepka D
J Cancer Educ; 2020 Oct; 35(5):1017-1025. PubMed ID: 31222578
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus-associated oropharynx cancer (HPV-OPC): treatment options.
Chau NG; Rabinowits G; Haddad RI
Curr Treat Options Oncol; 2014 Dec; 15(4):595-610. PubMed ID: 25240410
[TBL] [Abstract][Full Text] [Related]
19. Stepped Behavioral and Biological Screening for Oral Oncogenic HPV DNA in Middle-aged and Elderly Adults: A Feasibility Study.
Day AT; Sample RA; Salley JR; Oliver D; Dahlstrom KR; Sturgis EM; Tiro JA
Cancer Prev Res (Phila); 2023 Mar; 16(3):127-132. PubMed ID: 36596658
[TBL] [Abstract][Full Text] [Related]
20. Elevating dental training to prioritize prevention efforts for reducing HPV-related oropharyngeal cancer incidence.
Nelson JD; Lubker I; Bowers L; Neville B
J Dent Educ; 2021 Jun; 85(6):835-846. PubMed ID: 33690898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
